Cystatin C in risk prediction after transcatheter aortic valve replacement: a retrospective analysis

Cystatin C in risk prediction after transcatheter aortic valve replacement: a retrospective analysis

Abstract Aims No study has evaluated the prognostic value of the chronic kidney disease (CKD) classification by cystatin C‐based estimated glomerular filtration rate (eGFR) (CKDCys classification) in patients undergoing transcatheter aortic valve replacement (TAVR). This study aimed to compare the p...

Full description

Bibliographic Details
Main Authors: Kensuke Kuwabara, Kan Zen, Masaki Yashige, Kazuaki Takamatsu, Nobuyasu Ito, Yoshito Kadoya, Michiyo Yamano, Tetsuhiro Yamano, Takeshi Nakamura, Hitoshi Yaku, Satoaki Matoba
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:ESC Heart Failure
Subjects:
CKD
Creatinine
Cystatin C
Glomerular filtration rate
Transcatheter aortic valve replacement
Online Access:https://doi.org/10.1002/ehf2.13977

Internet

https://doi.org/10.1002/ehf2.13977

Similar Items